Deutetrabenazine
| Product Name | Deutetrabenazine |
|---|---|
| Alternate Names | Tetrabenazine Stable Isotopes, Stable Isotopes of Tetrabenazine |
| CAT No. | CS-O-37095 |
| CAS No. | 1392826-25-3 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 323.46 g/mol |
| Mol. For. | C₁₉H₂₁D₆NO₃ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tetrabenazine |
| Smileys | CC(C)CC1CN2CCC3=CC(OC([2H])([2H])[2H])=C(C=C3C2CC1=O)OC([2H])([2H])[2H] |
| Canonical Smiles | CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC |
| InchIKey | MKJIEFSOBYUXJB-VFJJUKLQSA-N |
| Inchl | InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1/i3D3,4D3 |
| IUPAC | (3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Deutetrabenazine is a medication used to treat the symptoms of Huntington's disease. It works by reducing the amount of dopamine in the brain, which helps to improve the control of movement and reduce involuntary movements known as chorea. The drug is also used to treat tardive dyskinesia, a condition characterized by repetitive, involuntary movements of the face and body.
Deutetrabenazine is a derivative of tetrabenazine, which was first approved by the FDA in 2008. The chemical structure of the drug contains deuterium, a stable isotope of hydrogen, which allows for more precise dosing and a longer half-life. Deutetrabenazine is metabolized by the liver and excreted in the urine.
The recommended dosage of deutetrabenazine varies depending on the condition being treated and the individual patient's needs. It is typically taken once or twice a day with food. Common side effects of the drug include drowsiness, dry mouth, and headache. In rare cases, more serious side effects such as depression and suicidal thoughts may occur.
In conclusion, deutetrabenazine is a medication used to treat the symptoms of Huntington's disease and tardive dyskinesia. It is effective in reducing involuntary movements and improving motor control. The chemical structure of the drug contains deuterium, which allows for more precise dosing. Common side effects include drowsiness and dry mouth, and it should only be taken under the supervision of a healthcare professional.
Get an Instant Quote
Related Compounds
Tetrabenazine D6 | cis-2,3 dihydro tetrabenazine-D6 | Tetrabenazine-D7 | Trans (2,3)-Dihydrotetrabenazine 13C2 D6 | alpha-Hydroxy Tetrabenazine-d7 | Deutetrabenazine metabolite M1 | Dihydrotetrabenazine-D6 | Related trans tetrabenazine D6 | Cis-2,3 dihydrotetrabenazine 13C2 D6 | Deutetrabenazine metabolite M4 | Didehydro tetrabenazine-d6 | Tetrabenazine D3 (Mixture of 9&10 Methoxy D3) |